ストックスクリーナーアプリを入手
7.99
0.88%
0.07
アフターアワーズ：
8.27
0.28
+3.50%
Novavax Inc (NVAX) 最新ニュース
Moderna, Novavax rise as new bat coronavirus identified in China - MSN
Novavax to Report Q4 Earnings: Here's What You Can Expect - MSN
Novavax (NVAX) Declines More Than Market: Some Information for Investors - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - Kilgore News Herald
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax COVID-19 vaccine gets green light from CDC; will be available in coming weeks - The National Desk
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal - MSN
Novavax, Inc. (NASDAQ:NVAX) Receives $17.83 Consensus PT from Brokerages - MarketBeat
Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Price Target at $17.83 - MarketBeat
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Pending US vaccine decisions as Kennedy takes top health job - Reuters
Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider - GlobeNewswire Inc.
Novavax To Get $350 Mln For Unused COVID Shots From Canada - BW Healthcare World
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Novavax's CEO Stanley Erck To Retire - BW Healthcare World
Novavax (NVAX) Outperforms Broader Market: What You Need to Know - Yahoo Finance
(NVAX)Analyzing Novavax's Short Interest - Benzinga
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
- GuruFocus.com
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - MSN
Zacks Research Issues Positive Forecast for Novavax Earnings - MarketBeat
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zacks Research Has Positive Estimate for Novavax Q2 Earnings - MarketBeat
Novavax (NASDAQ:NVAX) Trading Down 5.7%Time to Sell? - MarketBeat
Novavax (NASDAQ:NVAX) Shares Down 5.7%Time to Sell? - MarketBeat
This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery - MSN
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit - MSN
(NVAX) Long Term Investment Analysis - Stock Traders Daily
New Strong Buy Stocks for January 30th - Yahoo Finance
Moderna stock rises following RFK Jr's comments - MSN
Nanopharmaceuticals Market Generated Opportunities, Future - openPR
Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025 - MSN
Moderna stock rises following RFK Jr's comments By Investing.com - Investing.com South Africa
Novavax (NASDAQ:NVAX) delivers shareholders strong 122% return over 1 year, surging 11% in the last week alone - Simply Wall St
Novavax falls after guidance cut on lower vaccine sales - MSN
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Novavax Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Novavax, Inc. (NASDAQ:NVAX) is Shah Capital Management's 2nd Largest Position - MarketBeat
Novavax, Inc. (NVAX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Novavax (XTER:NVV1) Short-Term Capital Lease Obligation : €9.68 Mil (As of Sep. 2024) - GuruFocus.com
Novavax (XTER:NVV1) Free Cash Flow : €-112.35 Mil (TTM As of Sep. 2024) - GuruFocus.com
Novavax (NASDAQ:NVAX) Shares Up 6.1%Here's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Novavax, Inc. (NVAX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads - Benzinga
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):